TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics
PLOS Computational Biology · 2026
DOI: 10.1371/journal.pcbi.1014058 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Chenxuan Zang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. Hauptthemen laut MEDLINE: Neoplasms, Gene Expression Profiling. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
The identification of tumor cells is pivotal for understanding tumor heterogeneity and the tumor microenvironment. Recent advances in spatially resolved transcriptomics (SRT) have revolutionized the way that transcriptomic profiles are characterized and have enabled the simultaneous quantification of transcript locations in intact tissue samples. SRT is a promising alternative method to study gene expression patterns in spatial domains. Nevertheless, the precise detection of tumor regions within intact tissue remains a great challenge. A common strategy for identifying tumor cells is via tumor-specific marker gene expression signatures, which are highly dependent on marker accuracy. Another effective approach is through aneuploid copy number alterations, as most types of cancer exhibit copy number abnormalities. Here, we introduce a novel computational method, called TUSCAN (TUmor Segmentation and Classification ANalysis in spatial transcriptomics), which constructs a spatial copy number variation profile to improve the accuracy of tumor region identification. TUSCAN combines gene information from SRT data and hematoxylin-and-eosin-staining image to annotate tumor sections and other benign tissues. We benchmark the performance of TUSCAN and several existing methods through the application to multiple datasets from different SRT platforms. We demonstrate that TUSCAN can effectively delineate tumor regions, with improved accuracy compared to other approaches. Additionally, the output of TUSCAN provides interpretable clonal evolution inferences that may lead to novel insights into disease development and potential druggable targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
ORCID-Profile: Chenxuan Zang, Ziyi Li
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Zang, C., Guo, C. C., Wang, Y., Wei, P., & Li, Z. (2026). TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1014058
Vancouver
Zang C, Guo CC, Wang Y, Wei P, Li Z. TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1014058
BibTeX
@article{Zang2026,
author = {Zang, Chenxuan and Guo, Charles C and Wang, Yaohong and Wei, Peng and Li, Ziyi},
title = {TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics},
journal = {PLOS Computational Biology},
year = {2026},
doi = {10.1371/journal.pcbi.1014058}
}
EUVIMED